Apr 22, 2026, 15:39 by ASAM Weekly Editors

A opioid receptor superagonist analgesic with minimal adverse effects

Apr 21, 2026, 11:24 by Sarah Shelson

Apr 20, 2026, 18:12 by Sarah Shelson

Apr 16, 2026, 13:50 by ASAM Weekly Editors

New ASAM Implementation Guide for Hospital and EDs

Apr 13, 2026, 19:31 by R. Corey Waller, MD, MS, FACEP, DFASAM

Patients with substance use disorder (SUD) have frequent touchpoints with general hospitals and emergency departments (EDs). Between 2014 and 2018, 11.9% of inpatient hospitalizations and 9.4% of ED visits were for patients with SUD. The toll of not treating SUD is enormous, with high rates of premature discharge, cost, and mortality after discharge.

Apr 8, 2026, 14:31 by Sarah Shelson

Apr 8, 2026, 10:28 by ASAM Weekly Editors

Do US Adults View Drug and Alcohol Addiction as a Health Condition?

Apr 1, 2026, 08:54 by ASAM Weekly Editors

Treating Opioid Use Disorder With Methadone in Pharmacies

Mar 30, 2026, 15:19 by Sarah Shelson

Mar 30, 2026, 09:00 by Sarah Shelson

Mar 27, 2026, 10:33 by Sarah Shelson

Mar 26, 2026, 15:32 by Sarah Shelson

Mar 26, 2026, 13:30 by Sarah Shelson

Mar 25, 2026, 11:23 by ASAM Weekly Editors

Cost-effectiveness of contingency management for methamphetamine use disorder: A model-based analysis

Mar 25, 2026, 08:00 by Sarah Shelson

Mar 20, 2026, 10:54 by Sarah Shelson

Mar 20, 2026, 10:39 by ASAM Weekly Editors

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders

Mar 18, 2026, 16:50 by Sarah Shelson

Mar 12, 2026, 11:59 by Sarah Shelson

Mar 11, 2026, 11:43 by ASAM Weekly Editors

Emergency Department–Initiated Buprenorphine for Opioid Use Disorder